Pharmacogenetics of antidepressants

Cites (418)

Items 401–431 of 431

1. Genetic Association Analysis of Functional Polymorphisms in Neuronal Nitric Oxide Synthase 1 Gene (NOS1) and Mood Disorders and Fluvoxamine Response in Major Depressive Disorder in the Japanese Population
   Takenori Okumura, Taro Kishi, Tomo Okochi, Masashi Ikeda, Tsuyoshi Kitajima, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Tomoko Tsunoka, Toshiya Inada et al. · 2009 · Neuropsychobiology
2. Simultaneous determination of fluoxetine and its metabolite p-trifluoromethylphenol in human liver microsomes using a gas chromatographic–electron-capture detection procedure
   Zhaoqian Liu, Tan Zhi-rong, Dan Wang, Song‐Lin Huang, Liansheng Wang, Hong‐Hao Zhou · 2002 · Journal of Chromatography B
3. Impact of Gene-Gender Effects of Adrenergic Polymorphisms on Hypothalamic-Pituitary-Adrenal Axis Activity in Depressed Patients
   Sibylle Häfner, Thomas C. Baghai, Cornelius Schüle, Daniela Eser, Maximilian Spraul, Peter Zill, Rainer Rupprecht, Brigitta Bondy · 2008 · Neuropsychobiology
4. Neuronal cell lines transfected with the dopamine D2 receptor gene promoter as a model for studying the effects of antidepressant drugs
   Marta Dziedzicka‐Wasylewska, Joanna Solich · 2004 · Molecular Brain Research
5. Association study of CREB1 with Major Depressive Disorder and related phenotypes
   John M. Hettema, Seon‐Sook An, Edwin J. C. G. van den Oord, Michael Churton Neale, Kenneth S. Kendler, Xiangning Chen · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
6. Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
   Gonzalo Laje, Silvia Paddock, Husseini K. Manji, Augustus John Rush, Alexander F. Wilson, Dennis S. Charney, Francis J. McMahon · 2008 · FOCUS The Journal of Lifelong Learning in Psychiatry
7. Association of glucocorticoid receptor polymorphisms with the susceptibility to major depressive disorder and treatment responses in Korean depressive patients
   Hwa‐Young Lee, Rhee-Hun Kang, Sang-Woo Han, Jong‐Woo Paik, Hun Soo Chang, Yoo Jung Jeong, Min‐Soo Lee · 2009 · Acta Neuropsychiatrica
8. Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1
   Holly A. Garriock, Steven P. Hamilton · 2009 · The Journal of Clinical Psychiatry
9. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance
   Laura Mandelli, Marianna Mazza, Giovanni Martinotti, Daniela Tavian, E. Colombo, Sara Missaglia, Marco Di Nicola, Diana De Ronchi, Gloria Negri, Roberto Colombo et al. · 2010 · Journal of Psychopharmacology
10. [Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].
    Aleksandra Rajewska‐Rager, Maria Skibińska, Aleksandra Szczepankiewicz, Paweł Kapelski, Monika Dmitrzak‐Węglarz, Anna Leszczyńska-Rodziewicz, Joanna Hauser · 2008 · PubMed
11. Rat β1-Adrenergic Receptor Regulatory Region Containing Consensus AP-2 Elements Recognizes Novel Transactivator Proteins
    Philbert Kirigiti, Yong-Feng Yang, Xiaorong Li, Biao Li, Clare N. Midson, Curtis A. Machida · 2000 · Molecular Cell Biology Research Communications
12. Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome
    James J. Crowley, Robert H. Lipsky, Irwin Lucki, Wade H. Berrettini · 2008 · Psychiatric Genetics
13. Moclobemide response in depressed patients: Association study with a functional polymorphism in the monoamine oxidase-A promoter
    D Müller, Thomas G. Schulze, Fabio M. Macciardi, Stephanie Ohlraun, M. Gross, Inga Bauer, Harald Scherk, Eva Kischkel, Helge Neidt, Yana V. Syagailo et al. · 2000 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
14. Genetic Polymorphism in MDR-1: A Tool for Examining Allelic Expression in Normal Cells, Unselected and Drug-Selected Cell Lines, and Human Tumors
    Lyn A. Mickley, Jongseok Lee, Zheng Weng · 1998 · Blood
15. Fine Mapping of the Human 5-HTR2a Gene to Chromosome 13q14 and Identification of Two Highly Polymorphic Linked Markers Suitable for Association Studies in Psychiatric Disorders
    DAVID A. CAMPBELL, D. Sundaramurthy, Alexander F. Markham, LORENZO F. PIERI · 1997 · Genetic Testing
16. Functional polymorphism
    2015 · The Dictionary of Genomics, Transcriptomics and Proteomics
17. A 6-week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1 Antagonist) in the Treatment of Major Depression
    James C. Ballenger · 2009 · Yearbook of Psychiatry and Applied Mental Health
18. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression
    D HRANILOVIC · 2004 · Biological Psychiatry
19. Long-Term Imipramine Treatment Increases Nitrate Levels in the Rat Hypothalamus
    Eiji Suzuki, Toshio Nakaki, Shigenobu Kanba, Futoshi Shintani, Hitoshi Miyaoka · 2003 · Cellular and Molecular Neurobiology
20. Polymorphisms in the 5-hydroxytryptamine 2A receptor and cytochrome P4502D6 genes synergistically predict fluvoxamine-induced side-effects in Japanese depressed patients
    Yutaro Suzuki, Kazushi Sawamura, Takuro Sugai, Naoki Fukui, Toshiyuki Someya · 2006 · International Clinical Psychopharmacology
21. Serotonin-2A-receptor and -transporter polymorphisms: Lack of association in patients with major depression
    Christo Minov, Thomas C. Baghai, Cornelius Schüle, Peter Zwanzger, Markus Schwarz, Peter Zill, Rainer Rupprecht, Brigitta Bondy · 2001 · European Neuropsychopharmacology
22. Editorial: Pragmatics and statistics in psychiatric genetics
    Douglas F. Levinson · 1997 · American Journal of Medical Genetics
23. The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men
    Thomas C. Baghai · 2004 · Neuroscience Letters
24. ABCB1 genotyping is crucial for treatment with drugs that are P-glycoprotein substrates
    Manfred Uhr · 2005 · Max Planck Institute for Plasma Physics
25. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
    Joanna Maj, Zofia Rogóż, Grażyna Skuza, Helena Sowińska · 1989 · PubMed
26. Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients
    直樹 福井 · 2008 · Institutional Repositories DataBase (IRDB)
27. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
    Hisashi Higuchi · 2010 · PubMed
28. 10.1016/s0084-3970(09)79058-9
    2000 · Time to knit
29. Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
    Tadic, A, Dan Rujescu, Müller, M J, R. Kohnen, Stassen, H H, A Szegedi, N. Dahmen · 2008 · Zurich Open Repository and Archive (University of Zurich)
30. Untitled work
    2000 · 10.1002/1098-2396(20001215)38:4
31. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse
    Van Pett, Kasia, Viau, Victor, Bittencourt, Jackson C., Chan, Raymond K.W., Li, Hui-Yun, Arias, Carlos, Prins, Gail S., Perrin, Marilyn, Vale, Wylie, Sawchenko, Paul E. · 2000 · The Journal of Comparative Neurology